A Study Evaluating APG-115 as a Single Agent or in Combination With APG-2575 in Subjects With T-PLL
Condition(s):T-Prolymphocytic LeukemiaLast Updated:November 28, 2023Recruiting
Include Studies Not Open or Pending
Condition(s):T-Prolymphocytic LeukemiaLast Updated:November 28, 2023Recruiting
Condition(s):T-cell Lymphomas; NK-Cell Lymphomas; T-cell Prolymphocytic Leukemia; T-cell Large Granular Lymphocyte LeukemiaLast Updated:November 7, 2023Recruiting
Condition(s):CLL; SLL; HCL; Richter´s Transformation; Leukemia, Prolymphocytic, B-Cell; Leukemia, Prolymphocytic, T-Cell; T-LGL Leukemia; NK-LGL LeukemiaLast Updated:March 25, 2024Recruiting
Condition(s):B-Cell Prolymphocytic Leukemia; Chronic Lymphocytic Leukemia; Peripheral T-Cell Lymphoma; Primary Cutaneous T-Cell Non-Hodgkin Lymphoma; Sezary Syndrome; T-Cell Prolymphocytic LeukemiaLast Updated:January 31, 2024Recruiting
Condition(s):Non Hodgkin Lymphoma (NHL); Peripheral T-cell Lymphoma (PTCL); Cutaneous T-Cell Lymphoma (CTCL); Large Granular Lymphocytic Leukemia (LGL-L); T-cell Prolymphocytic Leukemia (T-PLL); Solid TumorsLast Updated:August 3, 2023Recruiting
Condition(s):T-cell Lymphoma; NK-Cell Lymphoma; T-cell Prolymphocytic Leukemia; T-cell Large Granular Lymphocytic Leukemia; Chronic Lymphoproliferative Disorder of NK Cells; Aggressive NK-cell Leukemia; Systemic Epstein-Barr Virus Positive T-Cell Lymphoproliferative Disease of Childhood (Disorder); Systemic Epstein Barr Virus Positive T-Cell Lymphoproliferative Disease of Childhood; Chronic Active EBV Infection of T-and NK-Cell Type, Systemic Form; Hydroa Vacciniforme-Like Lymphoproliferative Disorder; Adult T-cell Leukemia/Lymphoma; Extranodal NK/T-cell Lymphoma, Nasal Type; Enteropathy-associated T-cell Lymphoma; Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma; Intestinal T-Cell Lymphoma, Not Otherwise Specified; Indolent T-Cell Lymphoproliferative Disorder of the Gastrointestinal Tract; Hepatosplenic T-cell Lymphoma; Subcutaneous Panniculitis-Like T-Cell Lymphoma; Mycosis Fungoides; Sezary Syndrome; Primary Cutaneous Anaplastic Large Cell Lymphoma; Primary Cutaneous T-cell Lymphoma; Primary Cutaneous CD8-Positive Aggressive Epidermotropic T-Cell Lymphoma; Primary Cutaneous Acral CD8-Positive T-Cell Lymphoma; Peripheral T-Cell Lymphoma, Not Otherwise Specified; Angioimmunoblastic T-cell Lymphoma; Follicular T-Cell Lymphoma; Nodal Peripheral T-Cell Lymphoma With TFH Phenotype; Anaplastic Large Cell Lymphoma, ALK-Positive; Anaplastic Large Cell Lymphoma, ALK-negative; Breast Implant-Associated Anaplastic Large Cell LymphomaLast Updated:December 13, 2023Recruiting
Condition(s):T-Cell Non-Hodgkin Lymphoma; Acute Myeloid Leukemia; Angioimmunoblastic T-cell Lymphoma; Enteropathy-Associated T-Cell Lymphoma; Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma; Peripheral T Cell Lymphoma; Anaplastic Large Cell Lymphoma; Adult T Cell Leukemia; Adult T Cell Lymphoma; T Cell Prolymphocytic Leukemia; Extranodal NK/T-cell Lymphoma; Transformed Mycosis Fungoides; Sezary Syndrome; Primary Cutaneous Gamma-Delta T-Cell Lymphoma; Hepatosplenic T-cell LymphomaLast Updated:October 12, 2023Recruiting
Condition(s):Leukemia, Acute; Myelodysplastic Syndromes; Myelomonocytic Leukemia, Chronic; T-cell Prolymphocytic Leukemia; CML; Myeloproliferative Disorders; Multiple Myeloma; Plasma Cell LeukemiaLast Updated:March 8, 2024Recruiting
Condition(s):Non Hodgkin Lymphoma; Richter Transformation; Multiple Myeloma; T-cell-prolymphocytic Leukemia; Acute Myeloid Leukemia; Acute Lymphocytic Leukemia; Myeodysplastic Syndrome; Myelodysplastic/Myeloproliferative Neoplasm; Myelofibrosis; Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma; Chronic Myelomonocytic Leukemia-2; Myelodysplastic Neoplasm in Blast PhaseLast Updated:March 29, 2023Recruiting
Condition(s):Prolymphocytic Leukemia; T-cell LeukemiaLast Updated:July 27, 2022Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.